Key result
Thrombolytic therapy is associated with significantly improved survival in acute pulmonary embolism.
Why the study?
Pulmonary embolism is a life-threatening cardiovascular disease frequently encountered in emergency departments, and the effects of clinical findings and treatment methods on prognosis and mortality require examination.
Population
206 patients with acute pulmonary embolism in a single center emergency department
Comparison
Thrombolytic therapy vs other treatments
Design
Retrospective cohort study
Authors
Loading...
May support thrombolysis in acute PE; hypothesis-generating and requires randomized confirmation.
Cohort (n=206)
No
p-value: p=<0.001
Ertekin et al. (2022) conducted a cohort in Acute pulmonary embolism (n=206). Thrombolytic therapy vs. Anticoagulant drug therapy was evaluated on Survival (p=<0.001). Thrombolytic therapy administered to patients with acute pulmonary embolism had a statistically significant positive effect on survival.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: